Skip to Content

BMS 250MG 6673 (Videx EC 250 mg)

Generic Name: didanosine

Pill with imprint BMS 250MG 6673 is White, Capsule-shape and has been identified as Videx EC 250 mg. It is supplied by Bristol-Myers Squibb.

Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Videx EC 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 250MG 6673

Videx EC

Generic Name:
BMS 250MG 6673
250 mg
19.00 mm
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
carboxymethylcellulose sodium
diethyl phthalate
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium hydroxide
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54569-5504 A-S Medication Solutions, LLC (repackager)
54868-5595 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.